Literature DB >> 21944624

Temporal artery biopsy as a means of diagnosing giant cell arteritis: is there over-utilization?

Brent J Goslin1, Mathew H Chung.   

Abstract

Temporal artery biopsy (TAB) is often recommended for patients suspected of having temporal arteritis. The sensitivity of TAB varies widely and is dependent upon a number of factors (e.g., number of biopsy specimens, corticosteroid pretreatment, specimen length). The purpose of this study was to determine the clinical utility of TAB in patients who are suspected of having giant cell arteritis (GCA). A retrospective review of patients who underwent TAB at Spectrum Health from January 1, 1998 to December 31, 2007 was performed. Forty-seven patients, ranging in age from 25 to 87 years (mean: 70.7 years), underwent 53 TABs. Females accounted for 72.3 per cent of the subjects. Positive biopsy results showing signs of GCA were obtained in 38.3 per cent of patients. Of patients who underwent biopsy, 78 per cent could have been excluded from the procedure based upon individual diagnostic criteria. Positive and negative biopsies had average lengths of 1.84 cm and 1.29 cm, respectively (P < 0.05). In the community hospital setting, patients suspected of having GCA are frequently recommended to undergo unnecessary TAB. We advocate for more careful selection of patients to undergo this diagnostic surgical procedure. In cases where TAB is needed, we recommend a biopsy length of > 2 cm to increase the accuracy of diagnosis.

Entities:  

Mesh:

Year:  2011        PMID: 21944624

Source DB:  PubMed          Journal:  Am Surg        ISSN: 0003-1348            Impact factor:   0.688


  4 in total

1.  [Giant cell arteritis: etiological knowledge and diagnostic challenge for pathologists].

Authors:  S C Schaefer; H A Lehr
Journal:  Pathologe       Date:  2012-05       Impact factor: 1.011

2.  [Bitemporal scalp necrosis : a very rare manifestation of giant cell arteritis].

Authors:  E M Valesky; M Wahle; S Vranes; M Wolter; R Kaufmann; M Meissner
Journal:  Z Rheumatol       Date:  2012-11       Impact factor: 1.372

3.  Temporal arteritis: improving patient evaluation with a new protocol.

Authors:  Michael Alberts
Journal:  Perm J       Date:  2013

Review 4.  Clinical pathways for patients with giant cell arteritis during the COVID-19 pandemic: an international perspective.

Authors:  Sarah L Mackie; Elisabeth Brouwer; Richard Conway; Kornelis S M van der Geest; Puja Mehta; Susan P Mollan; Lorna Neill; Michael Putman; Philip C Robinson; Sebastian E Sattui
Journal:  Lancet Rheumatol       Date:  2020-12-08
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.